LIGAND PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
LIGAND PHARMACEUTICALS INC has filed 2,270 SEC EDGAR filings since 13 Sep 1994

SEC filing history

Showing 776-800 of 1,000 matching filings.

Per page
25
Current page
32
UPLOAD

UPLOAD filing

Filing date
15 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2017
Reporting date
17 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2017
Reporting date
17 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Nov 2017
Reporting date
17 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Nov 2017
Reporting date
17 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Nov 2017
Reporting date
16 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
14 Nov 2017
Reporting date
14 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33093

CT ORDER filing

Filing date
13 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
13 Nov 2017
Reporting date
13 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
09 Nov 2017
Reporting date
09 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-33093

10-Q/A

Filing date
02 Nov 2017
Reporting date
01 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Oct 2017
Reporting date
13 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
10 Oct 2017
Reporting date
10 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
04 Oct 2017
Reporting date
04 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Sep 2017
Reporting date
05 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Aug 2017
Reporting date
23 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Aug 2017
Reporting date
18 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
22 Aug 2017
Reporting date
18 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33093

8-K

Filing date
21 Aug 2017
Reporting date
18 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Aug 2017
Reporting date
08 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .